Compare Sunrun Inc (RUN) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sunrun Inc vs Recursion Pharmaceuticals Inc — how do they compare? Sunrun Inc trades at $11.46 (market cap $2.73B), while Recursion Pharmaceuticals Inc trades at $3.07 (market cap $1.53B). The key difference: Sunrun Inc is the larger of the two by market cap, and Sunrun Inc is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| RUN | RXRX | |
|---|---|---|
Market Cap | $2.73B | $1.53B |
Sector | Technology | Health |
52-Week High | $21.41 | $6.79 |
52-Week Low | $9.07 | $2.84 |
Enterprise Value | $16.92B | $946.50M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Sunrun Inc
Sunrun Inc. is one of the largest residential solar, battery storage, and energy services companies in the United States. The company provides solar panel installations, battery backup systems, and energy management solutions to homeowners. Sunrun primarily uses a solar-as-a-service model, offering customers solar leases and power purchase agreements (PPAs), which allow homeowners to adopt solar energy with little to no upfront cost. The company's mission is to create a planet run by the sun.
Read more on RUN →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
